We found that the sensitivity and specificity for plasma membrane TRPV4 in high-grade DCIS cells were 0.75±0.19 (15/20) and 0.98±0.03 (61/62), respectively (95% confidence interval) (Figure 3I). The gene discussed is TRPV4; the disease is ductal breast carcinoma in situ.